The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
D000284:Administration, Oral; D000821:Animal Feed; D000818:Animals; D003622:Dapsone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D007700:Kinetics; D007918:Leprosy / Q000188:drug therapy*; D051379:Mice; D008826:Microbial Sensitivity Tests; D009166:Mycobacterium leprae / Q000187:drug effects* / Q000254:growth & development; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D003622:Dapsone; D012293:Rifampin